Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -91,863 | -91,148 | -39,209 | -17,014 | -16,054 |
| Depreciation Amortization | 4,606 | 4,383 | 1,448 | 240 | 129 |
| Income taxes - deferred | 6,180 | -7,800 | 0 | N/A | N/A |
| Accounts receivable | 149 | 3,708 | -1,693 | -2,796 | -315 |
| Accounts payable and accrued liabilities | -1,206 | -2,851 | 1,537 | 1,681 | -670 |
| Other Working Capital | -26,988 | -2,488 | 158,064 | 37,651 | -245 |
| Other Operating Activity | 20,266 | 10,120 | 34,663 | -397 | 2,923 |
| Operating Cash Flow | $-88,856 | $-86,076 | $154,810 | $19,365 | $-14,232 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,154 | -23,887 | -2,174 | -782 | -170 |
| Net Acquisitions | N/A | N/A | -14,321 | N/A | N/A |
| Purchase Of Investment | -260,435 | -359,500 | -359,378 | N/A | N/A |
| Sale Of Investment | 354,530 | 351,322 | 77,885 | 0 | N/A |
| Investing Cash Flow | $88,941 | $-32,065 | $-297,988 | $-782 | $-170 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 308 | 3,031 |
| Debt Repayment | N/A | N/A | N/A | -200 | N/A |
| Common Stock Issued | 82,054 | 38,641 | 151,656 | 49 | 16 |
| Other Financing Activity | 0 | 4,444 | 22,522 | 92,184 | 16,192 |
| Financing Cash Flow | $82,054 | $43,085 | $174,178 | $92,341 | $19,239 |
| Exchange Rate Effect | 543 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 75,400 | 150,456 | 119,456 | 8,532 | 3,695 |
| End Cash Position | 158,082 | 75,400 | 150,456 | 119,456 | 8,532 |
| Net Cash Flow | $82,682 | $-75,056 | $31,000 | $110,924 | $4,837 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88,856 | -86,076 | 154,810 | 19,365 | -14,232 |
| Capital Expenditure | -5,154 | -23,887 | -2,174 | -782 | -170 |
| Free Cash Flow | -94,010 | -109,963 | 152,636 | 18,583 | -14,402 |